Ana Paula Helfer Schneider

Ana Paula Helfer Schneider

Auto-generated profile, based on publicly available information

Ana Paula Helfer Schneider

Universidade de Santa Cruz do Sul, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Globalization and Health
Verified
Journal Article
Open access
PDF file
ABAndrea Damaso Bertoldi
Andrea Damaso Bertoldi
AHAna P Helfer
Ana P Helfer
ACAline L Camargo
Aline L Camargo
NTNoêmia U L Tavares
Noêmia U L Tavares
PKPanos Kanavos
Panos Kanavos
To evaluate medicine prices, availability and affordability in Brazil, considering the differences across three types of medicines (originator brands, generics and similar medicines) and different types of facilities (private pharmacies, public sector pharmacies and “popular pharmacies”).

1 March 2012 in Revista Panamericana de Salud Pública
Verified
Journal Article
Closed access
PDF file
AHAna Paula Helfer
Ana Paula Helfer
ACAline Lins Camargo
Aline Lins Camargo
NTNoemia Urruth Leão Tavares
Noemia Urruth Leão Tavares
PKPanos Kanavos
Panos Kanavos
ABAndréa Dâmaso Bertoldi
Andréa Dâmaso Bertoldi
To assess the affordability by workers of drugs used for treatment of chronic diseases, as well as the availability of the reference, similar, or generic forms of these drugs in the public health care system. We employed the methodology recommended by the World Health Organization (WHO) and Health Action International (HAI) for the standardized collection of information on selling prices in the private sector and availability in the public health care system of drugs in six cities in the state of Rio Grande do Sul, Brazil. Data were collected from November 2008 to January 2009. Affordability was estimated as the number of salary days required for a worker receiving the national minimum wage to buy, in a private pharmacy, the amount of medication required for one month of treatment. Availability was assessed by the presence of these drugs in public health care system facilities. Twenty-two public facilities and 30 private pharmacies were studied. Of 21 drugs used for the treatment of seven chronic disorders, only nine were available free of charge in the six cities. Mean availability ranged from 83.3% (São Leopoldo) to 97.6% (Caxias do Sul). Affordability ranged from 0.4 to 10.5 salary days for reference drugs, 0.2 to 8.4 salary days for similar drugs, and 0.3 to 3.8 salary days for generic drugs. The overall availability of the drugs surveyed was higher than the 80% recommended by WHO. However, some treatments were not available, or had limited availability in the public system. Concerning affordability, the number of salary days required to buy these drugs may affect the continuation of drug treatments for chronic diseases.

29 November 2017 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
ASAna Paula Helfer Schneider
Ana Paula Helfer Schneider
MGMari Ângela Gaedke
Mari Ângela Gaedke
AGAnderson Garcez
Anderson Garcez
NBNêmora Tregnago Barcellos
Nêmora Tregnago Barcellos
VPVera Maria Vieira Paniz
Vera Maria Vieira Paniz

19 November 2021 in Revista Panamericana de Salud Pública
Verified
Journal Article
Open access
PDF file
ASAna Paula Helfer Schneider
Ana Paula Helfer Schneider
MGMari Ângela Gaedke
Mari Ângela Gaedke
JKJanine Koepp
Janine Koepp
ÉRÉboni Marília Reuter
Éboni Marília Reuter
CDCamilo Darsie
Camilo Darsie
GCGrupo Covid-Vrp
Grupo Covid-Vrp
Objective. To estimate the SARS-CoV-2 seroprevalence in a non-metropolitan area (Vale do Rio Pardo) in the state of Rio Grande do Sul, Brazil, and determine the association between seroprevalence and adherence to social distancing measures. Method. For the present population-based, cross-sectional study, data were collected in four stages from August to October 2020. SARS-CoV-2 seroprevalence was assessed using an IgG/IgM rapid test. Demographic, socioeconomic, clinical, and behavioral data were also collected, with administration of a three-question survey to determine adherence to social distancing measures with a focus on the level of social distancing practiced by participants, their routine activities, and circulation of people in the home. The association between sociodemographic data and social distancing was assessed using the chi-square test for linear trends in proportions, and the association between social distancing and seroprevalence was assessed using Poisson regression (95% confidence interval [95%CI]; P< 0.05). Results. Of 4 252 tested and interviewed participants, 11.8% (95%CI: 10.8; 12.8) did not adhere to social distancing measures. The prevalence of a positive rapid test was 4.7% in participants who did not practice social distancing and 1.9% in participants who adhered to social distancing measures (P < 0.05). The variables male sex, age 20 to 59 years, having completed high school, monthly family income ranging from R$ 3 136.00 to R$ 6 270.00, and living in rural areas were associated with non-adherence to social distancing (P< 0.05). Adherence to all social distancing measures provided protection against SARS-CoV-2 infection (prevalence ratio: 0.37; 95%CI: 0.19; 0.73). Conclusions. The results indicate a reduction in seroprevalence with the adherence to social distancing measures.

14 December 2016 in Saúde (Santa Maria)
Verified
Journal Article
Open access
PDF file
CGCristiane Carla Dressler Garske
Cristiane Carla Dressler Garske
MAMariana Portela de Assis
Mariana Portela de Assis
ASAna Paula Helfer Schneider
Ana Paula Helfer Schneider
EMEdiberto De Oliveira Machado
Ediberto De Oliveira Machado
LMLisoni Muller Morsch
Lisoni Muller Morsch
Interação medicamentosa indesejável está entre as principais causas dos problemas relacionados aos medicamentos, podendo ocasionar prejuízos na recuperação da saúde do paciente. O objetivo foi investigar a ocorrência de interações medicamentosas na farmacoterapia dos idosos atendidos na Farmácia Básica de Santa Cruz do Sul – RS. Estudo transversal, com coleta de dados entre Agosto a Setembro de 2014, através de entrevista individual. As interações medicamentosas foram obtidas através do software Micromedex® Solutions. Dos 204 regimes terapêuticos analisados, 54,4% continham pelo menos uma interação medicamentosa. A gravidade das interações encontradas foi: menor (n=26), moderada (n=160) e maior (n=45). O Ácido Acetilsalicílico teve a maior prevalência (23,8%) de interações, e Hidroclorotiazida foi o mais prescrito (18,6%). O manejo clínico mais indicado para as interações foi monitorização do paciente (73,6%). A identificação das interações permite tratamentos mais efetivos, menos complicações, racionalidade dos medicamentos, melhorias na qualidade das prescrições e na qualidade de vida dos pacientes.Descritores: Idosos; Farmacoterapia; Interações Medicamentosas.

29 March 2017 in Saúde e Pesquisa
Verified
Journal Article
Open access
PDF file
CGCristiane Carla Dressler Garske
Cristiane Carla Dressler Garske
BBBetina Lourdes Brixner
Betina Lourdes Brixner
AFAlice Pereira Freitas
Alice Pereira Freitas
ASAna Paula Helfer Schneider
Ana Paula Helfer Schneider
A identificação e prevenção de interações entre medicamentos estão diretamente relacionadas com a segurança do paciente e são de grande importância no ambiente hospitalar. O objetivo deste trabalho foi identificar e avaliar a existência de interações medicamentosas potenciais na farmacoterapia prescrita. Trata-se de estudo observacional, com 308 prescrições de 195 pacientes internados na Unidade de Terapia Intensiva de um hospital de ensino, realizado de agosto a dezembro de 2015. Para identificação das interações utilizou-se a base de dados Micromedex®. Das 308 prescrições analisadas, 101 apresentaram pelo menos uma interação medicamentosa, totalizando 173 interações, referentes a 71 pacientes. Destes, 43 eram do sexo masculino, com idade média de 61,9 anos. A média de internação na unidade foi de 7 dias. Nas 101 prescrições que apresentaram interações medicamentosas, foi prescrito o total de 1.349 medicamentos com média de 13,3 medicamentos/paciente/dia. Identificar essas interações possibilita evitar situações de insucesso terapêutico e toxicidade medicamentosa.